MARKET

PRCT

PRCT

Procept Biorobotics Corp
NASDAQ
35.43
+2.25
+6.78%
After Hours: 35.52 +0.09 +0.25% 19:55 12/04 EST
OPEN
33.44
PREV CLOSE
33.18
HIGH
36.04
LOW
33.01
VOLUME
2.38M
TURNOVER
--
52 WEEK HIGH
99.60
52 WEEK LOW
27.80
MARKET CAP
1.98B
P/E (TTM)
-23.0379
1D
5D
1M
3M
1Y
5Y
1D
PROCEPT BioRobotics Price Target Cut to $51.00/Share From $56.00 by Morgan Stanley
Dow Jones · 2d ago
Morgan Stanley Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $51
Benzinga · 2d ago
Procept BioRobotics price target lowered to $51 from $56 at Morgan Stanley
TipRanks · 2d ago
Weekly Report: what happened at PRCT last week (1124-1128)?
Weekly Report · 3d ago
Weekly Report: what happened at PRCT last week (1117-1121)?
Weekly Report · 11/24 10:01
First Week of July 2026 Options Trading For PROCEPT BioRobotics (PRCT)
NASDAQ · 11/21 16:10
PROCEPT BioRobotics To Spotlight Aquablation Growth At Piper Sandler Event Next Month
NASDAQ · 11/21 11:19
Artisan Global Discovery Fund: Q3 Delivers Strong Results Amid Trimming And Exits
Seeking Alpha · 11/20 13:40
More
About PRCT
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.

Webull offers Procept Biorobotics Corp stock information, including NASDAQ: PRCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PRCT stock methods without spending real money on the virtual paper trading platform.